| Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy DB Johnson, MV Estrada, R Salgado, V Sanchez, DB Doxie, SR Opalenik, ... Nature communications 7 (1), 10582, 2016 | 506 | 2016 |
| Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy JK Bailur, SS McCachren, DB Doxie, M Shrestha, K Pendleton, AK Nooka, ... JCI insight 4 (11), 2019 | 137 | 2019 |
| Single cell analysis of human tissues and solid tumors with mass cytometry N Leelatian, DB Doxie, AR Greenplate, BC Mobley, JM Lehman, ... Cytometry Part B: Clinical Cytometry 92 (1), 68-78, 2017 | 111 | 2017 |
| Preparation of side-chain 18-e cobaltocenium-containing acrylate monomers and polymers L Ren, CG Hardy, S Tang, DB Doxie, N Hamidi, C Tang Macromolecules 43 (22), 9304-9310, 2010 | 73 | 2010 |
| High-dimensional single-cell cancer biology JM Irish, DB Doxie High-dimensional single cell analysis: mass cytometry, multi-parametric flow …, 2014 | 65 | 2014 |
| Preparing viable single cells from human tissue and tumors for cytomic analysis N Leelatian, DB Doxie, AR Greenplate, J Sinnaeve, RA Ihrie, JM Irish Current protocols in molecular biology 118 (1), 25C. 1.1-25C. 1.23, 2017 | 55 | 2017 |
| Preparation of cobaltocenium-labeled polymers by atom transfer radical polymerization L Ren, J Zhang, CG Hardy, D Doxie, B Fleming, C Tang Macromolecules 45 (5), 2267-2275, 2012 | 39 | 2012 |
| Computational immune monitoring reveals abnormal double-negative T cells present across human tumor types AR Greenplate, DD McClanahan, BK Oberholtzer, DB Doxie, CE Roe, ... Cancer Immunology Research 7 (1), 86-99, 2019 | 31 | 2019 |
| Risk-associated alterations in marrow T cells in pediatric leukemia JK Bailur, SS McCachren, K Pendleton, JC Vasquez, HS Lim, A Duffy, ... JCI insight 5 (16), 2020 | 24 | 2020 |
| Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough … MI Azeem, AK Nooka, U Shanmugasundaram, N Cheedarla, S Potdar, ... Blood cancer discovery 4 (2), 106-117, 2023 | 19 | 2023 |
| Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016; 7: 10582 DB Johnson, MV Estrada, R Salgado, V Sanchez, DB Doxie, SR Opalenik, ... Epub 2016/01/30. https://doi. org/10.1038/ncomms10582 PMID: 26822383, 0 | 13 | |
| Comprehensive characterization of the multiple myeloma immune microenvironment using integrated scRNA-seq, CyTOF, and CITE-seq analysis L Yao, RG Jayasinghe, BH Lee, SS Bhasin, W Pilcher, DB Doxie, ... Cancer Research Communications 2 (10), 1255-1265, 2022 | 12 | 2022 |
| BRAF and MEK inhibitor therapy eliminates Nestin‐expressing melanoma cells in human tumors DB Doxie, AR Greenplate, JS Gandelman, KE Diggins, CE Roe, ... Pigment cell & melanoma research 31 (6), 708-719, 2018 | 12 | 2018 |
| HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior MF Senosain, Y Zou, T Novitskaya, G Vasiukov, AB Balar, DJ Rowe, ... Scientific Reports 11 (1), 14424, 2021 | 10 | 2021 |
| Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun 7: 10582 DB Johnson, MV Estrada, R Salgado, V Sanchez, DB Doxie, SR Opalenik, ... | 7 | 2016 |
| Integrated Cytof, Scrna-Seq and Cite-Seq Analysis of Bone Marrow Immune Microenvironment in the Mmrf Commpass Study L Yao, RG Jayasinghe, BE Thomas, SS Bhasin, N Fernandez, T Kourelis, ... Blood 136, 28-29, 2020 | 4 | 2020 |
| Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy. JCI Insight 2019; 5. doi: doi: 10.1172/jci. insight … JK Bailur, SS McCachren, DB Doxie | 3 | |
| Engineering Improved CAR T Cell Products with A Multi‐Cytokine Particle Platform for Hematologic and Solid Tumors HK Lin, B Uricoli, R Freeman, AKMN Hossian, Z He, JYL Anderson, ... Advanced Healthcare Materials, 2302425, 2024 | 1 | 2024 |
| Abstract CT262: Durable responses following anti-TIGIT (BMS-986207) and anti-LAG3 (BMS-980616) in combination with pomalidomide in relapsed myeloma: MMRF MyCheckpoint trial HJ Cho, S Richard, A Lesokhin, N Biran, B Paul, R Vij, M Pianko, D Doxie, ... Cancer Research 83 (8_Supplement), CT262-CT262, 2023 | 1 | 2023 |
| Association of race/ethnicity with innate immune tumor microenvironment of children with B-acute lymphoblastic leukemia JR Gilbert, HS Sabnis, R Radzievski, DB Doxie, D DeRyckere, ... Journal for immunotherapy of cancer 10 (6), 2022 | 1 | 2022 |
